140 related articles for article (PubMed ID: 25316266)
1. Melanoma-associated antigen genes: a new trend to predict the prognosis of breast cancer patients.
Abd-Elsalam EA; Ismaeil NA
Med Oncol; 2014 Nov; 31(11):285. PubMed ID: 25316266
[TBL] [Abstract][Full Text] [Related]
2. [Detection rate of MAGE-A1-A6 mRNA in the peripheral blood of cancer patients].
Novikov DV; Belova TV; Pegov RG; Aliasova AA; Morozova PN; Kniazev DI; Kalugin AV; Kontorshchikova KN; Baryshnikov AIu; Novikov VV
Klin Lab Diagn; 2009 Apr; (4):25-7. PubMed ID: 19514330
[TBL] [Abstract][Full Text] [Related]
3. The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma.
Kwon S; Kang SH; Ro J; Jeon CH; Park JW; Lee ES
Cancer; 2005 Jul; 104(2):251-6. PubMed ID: 15937912
[TBL] [Abstract][Full Text] [Related]
4. Circulating cell-free cancer-testis MAGE-A RNA, BORIS RNA, let-7b and miR-202 in the blood of patients with breast cancer and benign breast diseases.
Joosse SA; Müller V; Steinbach B; Pantel K; Schwarzenbach H
Br J Cancer; 2014 Aug; 111(5):909-17. PubMed ID: 24983365
[TBL] [Abstract][Full Text] [Related]
5. Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes.
Miyashiro I; Kuo C; Huynh K; Iida A; Morton D; Bilchik A; Giuliano A; Hoon DS
Clin Chem; 2001 Mar; 47(3):505-12. PubMed ID: 11238304
[TBL] [Abstract][Full Text] [Related]
6. MAGE-A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer.
Gu L; Sang M; Yin D; Liu F; Wu Y; Liu S; Huang W; Shan B
Thorac Cancer; 2018 Apr; 9(4):431-438. PubMed ID: 29430849
[TBL] [Abstract][Full Text] [Related]
7. A new strategy for the diagnosis of MAGE-expressing cancers.
Park JW; Kwon TK; Kim IH; Sohn SS; Kim YS; Kim CI; Bae OS; Lee KS; Lee KD; Lee CS; Chang HK; Choe BK; Ahn SY; Jeon CH
J Immunol Methods; 2002 Aug; 266(1-2):79-86. PubMed ID: 12133624
[TBL] [Abstract][Full Text] [Related]
8. Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broad-spectrum tumor immunotherapy.
Graff-Dubois S; Faure O; Gross DA; Alves P; Scardino A; Chouaib S; Lemonnier FA; Kosmatopoulos K
J Immunol; 2002 Jul; 169(1):575-80. PubMed ID: 12077290
[TBL] [Abstract][Full Text] [Related]
9. MAGE A1-A6 RT-PCR and MAGE A3 and p16 methylation analysis in induced sputum from patients with lung cancer and non-malignant lung diseases.
Shin KC; Lee KH; Lee CH; Shin IH; Suh HS; Jeon CH
Oncol Rep; 2012 Apr; 27(4):911-6. PubMed ID: 22134685
[TBL] [Abstract][Full Text] [Related]
10. Expression of melanoma-associated antigens in oral squamous cell carcinoma.
Ries J; Vairaktaris E; Mollaoglu N; Wiltfang J; Neukam FW; Nkenke E
J Oral Pathol Med; 2008 Feb; 37(2):88-93. PubMed ID: 18197853
[TBL] [Abstract][Full Text] [Related]
11. Expression of melanoma antigen-encoding genes (MAGE) by common primers for MAGE-A1 to -A6 in colorectal carcinomas among Koreans.
Park MS; Park JW; Jeon CH; Lee KD; Chang HK
J Korean Med Sci; 2002 Aug; 17(4):497-501. PubMed ID: 12172045
[TBL] [Abstract][Full Text] [Related]
12. Expression of MAGE-A12 in oral squamous cell carcinoma.
Mollaoglu N; Vairaktaris E; Nkenke E; Neukam FW; Ries J
Dis Markers; 2008; 24(1):27-32. PubMed ID: 18057533
[TBL] [Abstract][Full Text] [Related]
13. MAGE-A gene expression pattern in primary breast cancer.
Otte M; Zafrakas M; Riethdorf L; Pichlmeier U; Löning T; Jänicke F; Pantel K
Cancer Res; 2001 Sep; 61(18):6682-7. PubMed ID: 11559535
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries.
Serrano A; Lethé B; Delroisse JM; Lurquin C; De Plaen E; Brasseur F; Rimoldi D; Boon T
Int J Cancer; 1999 Nov; 83(5):664-9. PubMed ID: 10521804
[TBL] [Abstract][Full Text] [Related]
15. Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer.
Suzuki T; Yoshida K; Wada Y; Hamai Y; Sentani K; Oue N; Yasui W
Oncol Rep; 2007 Aug; 18(2):329-36. PubMed ID: 17611652
[TBL] [Abstract][Full Text] [Related]
16. Expression of MAGE-A1-A12 subgroups in the invasive tumor front and tumor center in oral squamous cell carcinoma.
Brisam M; Rauthe S; Hartmann S; Linz C; Brands RC; Kübler AC; Rosenwald A; Müller-Richter UD
Oncol Rep; 2016 Apr; 35(4):1979-86. PubMed ID: 26820613
[TBL] [Abstract][Full Text] [Related]
17. Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma.
Sarcevic B; Spagnoli GC; Terracciano L; Schultz-Thater E; Heberer M; Gamulin M; Krajina Z; Oresic T; Separovic R; Juretic A
Oncology; 2003; 64(4):443-9. PubMed ID: 12759544
[TBL] [Abstract][Full Text] [Related]
18. MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors.
Grau E; Oltra S; Martínez F; Orellana C; Cañete A; Fernández JM; Hernández-Martí M; Castel V
J Cancer Res Clin Oncol; 2009 Apr; 135(4):523-31. PubMed ID: 18820946
[TBL] [Abstract][Full Text] [Related]
19. Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma.
Yin B; Zeng Y; Wang X; Liu G; Zhang M; Song Y
Int J Clin Exp Pathol; 2014; 7(7):4112-9. PubMed ID: 25120790
[TBL] [Abstract][Full Text] [Related]
20. MAGE-A1-6 expression in patients with head and neck squamous cell carcinoma: impact on clinical patterns and oncologic outcomes.
Noh ST; Lee HS; Lim SJ; Kim SW; Chang HK; Oh J; Jeon CH; Park JW; Lee KD
Int J Clin Oncol; 2016 Oct; 21(5):875-882. PubMed ID: 27230992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
